本页面由Tiger Trade Technology Pte. Ltd.提供服务

Propanc Biopharma, Inc.

0.4400
-0.0457-9.41%
盘后:0.4305-0.0095-2.16%18:09 EDT
成交量:19.56万
成交额:8.82万
市值:278.57万
市盈率:-0.02
高:0.4899
开:0.4887
低:0.4250
收:0.4857
52周最高:47.50
52周最低:0.4250
股本:633.11万
流通股本:125.01万
量比:0.63
换手率:15.65%
股息:- -
股息率:- -
每股收益(TTM):-17.6157
每股收益(LYR):-371.2241
净资产收益率:-161.86%
总资产收益率:-70.14%
市净率:0.30
市盈率(LYR):0.00

数据加载中...

2026/10/05

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/09/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/07/17

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/07/14

重要事件披露

Form 8-K - Current report
2026/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/16

SEC问询函

Form CORRESP - Correspondence
2026/04/10

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/20

SEC问询函

Form CORRESP - Correspondence
2026/02/19

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/02/17

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/02/13

SEC问询函

Form CORRESP - Correspondence
2026/02/11

SEC问询函

Form CORRESP - Correspondence
2026/02/02

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/01/07

重要事件披露

Form 8-K - Current report
2026/01/07

SEC问询函

Form CORRESP - Correspondence
2025/12/30

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/10

重要事件披露

Form 8-K - Current report
2025/10/14

重要事件披露

Form 8-K - Current report